Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases
Diabetes & Metabolism Journal · 2024
DOI: 10.4093/dmj.2023.0213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, 2024. Verfasst von Songling Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Laboratory of Emergency Medicine, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, …. Hauptthemen laut MEDLINE: Mitophagy, Obesity, Mitochondria. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, 1.3.5 Project for Disciplines of Excellence, Center of Excellence-International Cooperation Initiative.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Several mitochondrial dysfunctions in obesity and diabetes include impaired mitochondrial membrane potential, excessive mitochondrial reactive oxygen species generation, reduced mitochondrial DNA, increased mitochondrial Ca2+ flux, and mitochondrial dynamics disorders. Mitophagy, specialized autophagy, is responsible for clearing dysfunctional mitochondria in physiological and pathological conditions. As a paradox, inhibition and activation of mitophagy have been observed in obesity and diabetes-related heart disorders, with both exerting bidirectional effects. Suppressed mitophagy is beneficial to mitochondrial homeostasis, also known as benign mitophagy. On the contrary, in most cases, excessive mitophagy is harmful to dysfunctional mitochondria elimination and thus is defined as detrimental mitophagy. In obesity and diabetes, two classical pathways appear to regulate mitophagy, including PTEN-induced putative kinase 1 (PINK1)/Parkin-dependent mitophagy and receptors/adapters-dependent mitophagy. After the pharmacologic interventions of mitophagy, mitochondrial morphology and function have been restored, and cell viability has been further improved. Herein, we summarize the mitochondrial dysfunction and mitophagy alterations in obesity and diabetes, as well as the underlying upstream mechanisms, in order to provide novel therapeutic strategies for the obesity and diabetes-related heart disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Laboratory of Emergency Medicine, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
- Sichuan University-The Hong Kong Polytechnic University Institute for Disaster Management and Reconstruction, Chengdu, China.
- Disaster Medical Center, Sichuan University, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- 1.3.5 Project for Disciplines of Excellence
- Center of Excellence-International Cooperation Initiative
- China Postdoctoral Science Foundation
- Sichuan Provincial Department of Science and Technology
Zitieren
APA
Tang, S., Hao, D., Ma, W., Liu, L., Gao, J., Yao, P., Yu, H., Gan, L., & Cao, Y. (2024). Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0213
Vancouver
Tang S, Hao D, Ma W, Liu L, Gao J, Yao P, et al. Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2023.0213
BibTeX
@article{Tang2024,
author = {Tang, Songling and Hao, Di and Ma, Wen and Liu, Lian and Gao, Jiuyu and Yao, Peng and Yu, Haifang and Gan, Lu and Cao, Yu},
title = {Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases},
journal = {Diabetes & Metabolism Journal},
year = {2024},
doi = {10.4093/dmj.2023.0213}
}
EUVIMED